Large-scale testing (Phase 3)Study completedNCT01138657What this trial is testingEfficacy and Safety of Adalimumab in Patients With Active UveitisWho this might be right forUveitis AbbVie (prior sponsor, Abbott) 239
Large-scale testing (Phase 3)Study completedNCT02595398What this trial is testingSuprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious UveitisWho this might be right forUveitisUveitis, PosteriorUveitis, Anterior+2 more Clearside Biomedical, Inc. 160
Not applicableStudy completedNCT03155243What this trial is testingImpact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical PracticeWho this might be right forUveitis AbbVie 155
Post-approval studies (Phase 4)UnknownNCT05322070What this trial is testingFluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment UveitisWho this might be right forUveitis, Posterior Alimera Sciences 125
Large-scale testing (Phase 3)WithdrawnNCT01327664What this trial is testingStudy to Evaluate the Long Term Use of Treatment With AIN457 for UveitisWho this might be right forUveitis Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02255032What this trial is testingSuprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious UveitisWho this might be right forUveitisMacular EdemaUveitis, Posterior+3 more Clearside Biomedical, Inc. 22
Large-scale testing (Phase 3)Study completedNCT01124838What this trial is testingEfficacy and Safety of Adalimumab in Subjects With Inactive UveitisWho this might be right forUveitis AbbVie (prior sponsor, Abbott) 261
Testing effectiveness (Phase 2)Ended earlyNCT05384249What this trial is testingPhase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitisWho this might be right forUveitis ACELYRIN Inc. 96
Large-scale testing (Phase 3)Ended earlyNCT02375685What this trial is testingLong-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)Who this might be right forChronic Uveitis Institut de Recherches Internationales Servier 71
Large-scale testing (Phase 3)Ended earlyNCT01747538What this trial is testingSafety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic TreatmentWho this might be right forUveitis XOMA (US) LLC 281
Large-scale testing (Phase 3)Study completedNCT03097315What this trial is testingSuprachoroidal Injection of CLS-TA in Patients With Non-infectious UveitisWho this might be right forUveitisUveitis, PosteriorUveitis, Anterior+2 more Clearside Biomedical, Inc. 38
Large-scale testing (Phase 3)Study completedNCT02251938What this trial is testingA Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development ProgramWho this might be right forNon-Infectious Uveitis of the Posterior Segment of the Eye Santen Inc. 60
Not applicableStudy completedNCT03339102What this trial is testingPost-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis PatientsWho this might be right forNon-infectious Intermediate, Posterior and Panuveitis AbbVie 158
Large-scale testing (Phase 3)Study completedNCT00404742What this trial is testingLX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-UveitisWho this might be right forUveitis, PosteriorUveitis, IntermediatePanuveitis Lux Biosciences, Inc. 232
Testing effectiveness (Phase 2)Ended earlyNCT05953688What this trial is testingPOC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIUWho this might be right forUveitis Posterior Non-InfectiousUveitis, IntermediateNoninfectious Panuveitis Alumis Inc 36
Large-scale testing (Phase 3)Study completedNCT00333814What this trial is testingThe Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior UveitisWho this might be right forIntermediate UveitisPosterior Uveitis Allergan 229
Not applicableNot Yet RecruitingNCT05928754What this trial is testingProspective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiSWho this might be right forNon-infectious Uveitis Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 2,000
Not applicableActive Not RecruitingNCT07262437What this trial is testingTargeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine ProfilesWho this might be right forUveitis Posterior Non-InfectiousInflammation EyeUveitis+1 more University of Milan 220
Testing effectiveness (Phase 2)Study completedNCT01526889What this trial is testingSafety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,Who this might be right forNon-infectious Intermediate UveitisNon-infectious Posterior UveitisNon-infectious Panuveitis Novartis Pharmaceuticals 25
Early research (Phase 1)Study completedNCT00280826What this trial is testingEfalizumab to Treat UveitisWho this might be right forUveitisMacular Edema National Eye Institute (NEI) 6